Trial Profile
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Dexmedetomidine Used for Sedation During Elective Awake Fiberoptic Intubation
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Midazolam
- Indications Sedation
- Focus Adverse reactions; Registrational
- Sponsors Hospira
- 29 Mar 2014 New trial record